Fundación Josep Carreras Contra la Leucemia

Recent papers from Fundación Josep Carreras Contra la Leucemia

1. Comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL by Optical Genome Mapping and Targeted NGSBlood Advances · 2026
2. Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive ImmunotherapyCancers · 2026
3. Late onset non-infectious pulmonary complications and pre-transplant pulmonary function as prognostic factors in allo-HCT using post-transplant cyclophosphamideFrontiers in Immunology · 2026
4. Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5qBlood Advances · 2026
5. Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasmsBlood Advances · 2026
6. Use of mesenchymal stromal cells derived from the Wharton’s jelly of human umbilical cord for treating patients with steroid-resistant graft versus host disease: predicting clinical response by a validated immunopotency assayScientific Reports · 2026
7. Endothelial cell damage in patients with acute graft versus host disease receiving treatment with extracorporeal photopheresisFrontiers in Immunology · 2026
8. Not Missing the Notch: Detection Challenges of Juxtamembrane NOTCH1 Variant Detection in T‐Cell Acute Lymphoblastic LeukemiaJournal of Clinical Laboratory Analysis · 2026
9. Final results from ZZFIRST: A randomized phase 2 trial of enzalutamide (EZ) and talazoparib (TALA) in metastatic hormone-naïve prostate cancer (mHNPC).Journal of Clinical Oncology · 2026
10. Evolving Paradigms in the Treatment of Philadelphia Chromosome–Positive ALLAmerican Society of Clinical Oncology Educational Book · 2026
11. Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein responseBlood Cancer Journal · 2026
12. Accuracy and variability of locoregional staging in T1 rectal cancer: nationwide multicentre cohort studyBJS Open · 2025
13. Incidence, Risk Factors and Outcomes of Sinusoidal Obstruction Syndrome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With PTCy-Based ProphylaxisBiology of Blood and Marrow Transplantation · 2026
14. Toward standardized iPSC testing: Insights from a multi-year international Quality Assessment RoundStem Cell Reports · 2026
15. Endothelial USP8 is essential for angiogenesisAngiogenesis · 2026
16. Inclusive Practices for Safe and Equitable Donor AssessmentTransplantation and Cellular Therapy · 2026
17. Enhanced efficacy of a specific HDAC3 inhibitor in combination with 5-azacitidine against diffuse large B-cell lymphomaBlood Neoplasia · 2026
18. Avatrombopag for post‐transplant thrombocytopenia following allogeneic haematopoietic stem cell transplantation: A single‐centre retrospective studyBritish Journal of Haematology · 2026
19. Robust, scalable and xeno-free protocol for differentiating human induced pluripotent stem cells into functional macrophagesFrontiers in Immunology · 2026
20. Allo-HCT with post-transplant cyclophosphamide in older adults: similar safety and a viable option compared to younger adultsFrontiers in Immunology · 2026